The potential of CpG oligodeoxynucleotides as mucosal adjuvants.

Critical reviews in Immunology, 2001 - europepmc.org
The development of mucosal vaccines for humans has been hindered by the lack of safe yet
effective mucosal adjuvants. Bacterial toxins are commonly used as adjuvants in animal …
被引用次数：60 相关文章

The potential of CpG oligodeoxynucleotides as mucosal adjuvants

MJ McCluskie, RD Weeratna… - Critical reviews in …, 2001 - pubmed.ncbi.nlm.nih.gov
The development of mucosal vaccines for humans has been hindered by the lack of safe yet
effective mucosal adjuvants. Bacterial toxins are commonly used as adjuvants in animal …

[引用][C] The potential of CpG oligodeoxynucleotides as mucosal adjuvants.

MJ McCluskie - Crit Rev Immunol, 2001 - cir.nii.ac.jp